Impact Biomedicines, Inc.
Overview
Impact Biomedicines is a biotechnology company focused on developing therapies for patients with myeloproliferative neoplasms and other cancers. It operates as a subsidiary of Celgene Corporation, a global biopharmaceutical company known for its innovative cancer treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Impact Biomedicines, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.